ATXN3 and neurodegenerative disease: Our data-driven results indicate that SCA3 follows one uniform pattern of atrophy evolution, setting it apart from the heterogeneity seen in other neurodegenerative diseases like Alzheimer's disease or frontotemporal dementia.11